Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Healthy × Control Groups × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 18 Neoplasms 12 Colorectal Neoplasms 5 Pain, Postoperative 4 Fatigue 4 Thyroid Neoplasms 3 Stomatitis 3 Pain 3 Depression 3 Carcinoma, Hepatocellular 3 Anxiety Disorders 3 Sleep Initiation and Maintenance Disorders 2 Polycystic Ovary Syndrome 2 Parasomnias 2 Motor Activity 2 Malnutrition 2 Lung Neoplasms 2 Liver Neoplasms 2 Agnosia 2 Vomiting 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Unilateral U/S PVB 1 Ulcer 1 Thyroid Nodule 1 Syndrome 1 Stomach Neoplasms 1 Sarcopenia 1 Respiratory Aspiration 1

Interventions

pimodivir 1 Sunitinib 1 Rosuvastatin Calcium 1 Olive Oil 1 Midazolam 1 Interviews as Topic 1 Cyclosporine 1 Control Groups 1 Blood Specimen Collection 1 Adalimumab 1 (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01408459 2025-05-16

DAPH

University of Illinois at Chicago

Phase NA Completed

37 enrolled 9 charts

Healthy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡